Introduction {#S1}
============

The type VI secretion system (T6SS) is a contact-dependent transmembrane nanomachine that uses a contractile mechanism to inject effectors into adjacent prokaryotic or eukaryotic cells ([@B47]; [@B50]; [@B23]). A typical T6SS apparatus is composed of 13 core subunits (TssA-TssM) and possesses a structure similar to that of a T4 bacteriophage tail ([@B14]; [@B17]; [@B114]). In an integral T6SS apparatus, the baseplate complex (TssAEFGK) is anchored to the cell membrane by the membrane complex (TssJLM), providing structural support. The needle sheath (TssBC), tail tube (TssD/Hcp), and spike complex (TssI/VgrG) form the injection apparatus, which is responsible for effector secretion ([@B17]; [@B82]). A dynamic T6SS secretion process contains assembly/extension, contraction/puncture, and disassembly of the sheath. Briefly, the membrane complex is formed at the initial stage. Subsequently, baseplate proteins are recruited for sheath/tube anchoring and extension. When attacking, the membrane-puncturing spike pierces target cells through sheath contraction, accompanied by energy consumption and load transportation. Consequently, various effectors are delivered into target cells in a one-step manner ([@B8]; [@B16]; [@B23]; [@B24]). Although some pathogen-associated T6SSs have been reported to be involved in bacterial pathogenesis ([@B69]; [@B5]; [@B51]), the primary function of T6SSs is to compete against rival bacteria in polymicrobial environments ([@B32]; [@B23]). However, other functions of T6SSs, such as resistance to amoeba predation ([@B112]), biofilm formation ([@B39]), and stress response ([@B99]; [@B109]), have also been reported.

The intestinal ecosystem is composed of a densely populated community of multiple microorganisms that may be beneficial or harmful to host health ([@B94]). In intestinal environments where nutrients and space are limited, microbes must use various strategies to coexist or compete with the host and other bacteria. In recent years, the contact-dependent T6SS nanomachine has attracted much attention for its role in interbacterial competition in the mammalian gut ([@B78]; [@B93]). T6SS mediated antagonism in the mammalian gut not only benefits the microbiota-mediated colonization resistance by preventing invasion of pathogens, but also assists some pathogens to battle with the resident microbiota to invade an ecosystem and cause disease. Thus, it was stated that there is secret bacterial warfare in the gut, due to the T6SS roles both in the intestinal commensal microbes and enteric pathogens ([@B78]; [@B40]). In this review, we have discussed recent studies on intestinal microorganisms with functional T6SS clusters and T6SS-dependent activities related to the intestinal microbial community and host health.

T6SS-Dependent Activities in Intestinal Ecosystem {#S2}
=================================================

Interference Competition Mediated by T6SS {#S2.SS1}
-----------------------------------------

Bacterial competition occurs as interference competition (killing of target cells with antibacterial weapons) or exploitation competition (consuming nutrients from the milieu) ([@B19]). As an anti-bacterial weapon, T6SSs were primarily considered to mediate interference competition in the intestinal microbiota. The antibacterial function of T6SSs relies primarily on injection of "anti-bacterial" effectors that target conserved, essential features of the bacterial cell, such as peptidoglycan ([@B72]), membrane phospholipids ([@B73]), nucleic acids ([@B61]), NAD^+^ ([@B103]), and the critical cell division protein FtsZ ([@B88]).

Commensal bacteria form a protective barrier that protects the host from bacterial pathogens ([@B9]). In healthy adult individuals, Bacteroidales are the most abundant order of bacteria in the intestinal microbiota ([@B34]). Recently, by performing extensive bioinformatics analyses and creating hidden Markov models for Bacteroidales Tss proteins, Coyne and colleagues identified 130 T6SS loci within 205 human gut Bacteroidales genomes. As Bacteroidales comprise approximately 50% of all colonic bacteria in many people, this suggested that T6SSs are distributed in about 25% of bacteria in the human colon ([@B27]; [@B26]). Moreover, more than 10^9^ T6SS-firing events were determined per minute per gram of colonic contents, further supporting the importance of this weapon in shaping gut microbiota composition ([@B100]). T6SS loci of the human gut Bacteroidales species segregate into three distinct genetic architectures (GA), termed GA1-GA3. GA1 and GA2 loci are present on conserved integrative conjugative elements (ICE) and are transferred between diverse human gut Bacteroidales strains via ICE. GA3 loci are not contained on conserved ICE and are confined to *Bacteroides fragilis* ([@B27], [@B26]). The GA3 T6SSs of *B. fragilis* antagonizes human gut Bacteroidales species *in vivo* using previously undescribed effectors, likely to create a locally protected niche in the human gut ([@B100]). The interbacterial interactions among symbiotic Bacteroidales species could be predicted according to the presence or absence of strain-specific effector/immunity (E/I) repertoires. Further, some of these strains may avoid contact-dependent killing by accumulating immunity genes to neutralize antibacterial effectors that they do not encode to persist in the gut ([@B100]). Importantly, symbiotic non-toxigenic *B. fragilis* strains could restrict enteric colonization by an enterotoxigenic *B. fragilis* strain, dependent on a functional T6S, to protect the host against intestinal inflammatory disease, suggesting a novel role of T6SS in colonization resistance ([@B46]; [@B18]).

Type VI secretion systems are widely distributed and have been proposed to be present in about 25% of all sequenced Gram-negative bacteria ([@B14]; [@B76]), including enteric pathogenic microorganisms, e.g., *Vibrio cholerae*, *Salmonella enterica*, *Shigella sonnei*, and *Yersinia pseudotuberculosis.* Thus, T6SS mediated antagonism in the mammalian gut both benefits microbiota-mediated colonization resistance by preventing pathogen invasion and facilitates some pathogens to battle resident microbiota to invade the ecosystem and cause disease. Some enteric pathogens could utilize T6SS-mediated antibacterial weapons to kill symbionts and establish within the host gut. For example, *S. enterica* Serovar Typhimurium uses T6SS to kill commensal *Klebsiella oxytoca* and enhance colonization of the mouse gut ([@B77]). With a functional T6SS, *S. sonnei* showed an advantage in competing against *E. coli* and *Shigella flexneri* both *in vitro* and *in vivo*, which may explain the dominance and increasing global prevalence of *S. sonnei* in developed countries worldwide ([@B3]). Constitutive T6SS expression provides *V. cholerae* with an advantage in intra-specific and inter-specific competition, such that T6SS-dependent toxicity toward other bacteria could enhance *V. cholerae* survival in the environment and/or during colonization of a host ([@B63]; [@B91]; [@B38]). Through transcriptome sequencing (RNA-Seq), T6SSs and their associated toxins in the gut symbiont of 28 *Snodgrassella alvi* strains from diverse *Apis* and *Bombus* species were analyzed. T6SS-associated Rhs toxins with antibacterial activity could mediate both intraspecific and interspecific competition among *S. alvi* strains and other bee gut microbes. Furthermore, extensive recombination and horizontal transfer of toxin/immunity genes between strains in the gut microbiota have resulted in tremendous diversity in their toxin repertoires, which suggest that T6SS-mediated competition may be an important driver of coevolution ([@B86]). These studies showed that enteric pathogens could use their T6SSs for interbacterial competition *in vivo* and for niche occupancy.

Besides bacterial competitors, T6SS was also found to target some single cell eukaryotic competitors, including amoebae and fungi. In fact, T6SS was first identified by screening *V. cholerae* mutants that failed to kill the social amoeba *Dictyostelium discoideum*, and the lipid-binding effector VasX was found to be required for T6SS-mediated amoeba killing, possibly through plasma membrane perturbations ([@B70]; [@B64]; [@B112]). T6SSs in *Pseudomonas syringae* and *Serratia marcescens* were reported to be required for competition against other single cell eukaryotic organisms, i.e., yeast and fungi ([@B45]; [@B90]). The first anti-fungal T6SS effectors, Tfe1 and Tfe2, were identified in *S. marcescens*. Tfe1 causes plasma membrane depolarization without formation of a specific pore, while Tfe2 disrupts nutrient uptake and amino acid metabolism, and induces autophagy ([@B90]). Since single cell eukaryotes are important components of the intestinal microbiota ([@B25]), it is not surprising that intestinal bacteria might deploy anti-eukaryotic T6SSs to compete for nutrients and space against co-habiting microbial eukaryotes.

Exploitation Competition Meditated by T6SS {#S2.SS2}
------------------------------------------

As essential micronutrients are involved in a wide range of cellular processes (e.g., DNA replication, respiration, and energy generation), transit of these metal ions is a crucial component of host-microbe interactions, including those in the gastrointestinal tract ([@B85]). For example, *E. coli* mutants defective in catecholate siderophore production show impaired murine gut colonization ([@B68]). Without a high-affinity zinc transporter, *Campylobacter jejuni* is unable to replicate or colonize the gastrointestinal tract, as quantities of zinc in the gastrointestinal tract are reduced by the host ([@B41]). Thus, competition for micronutrients in the gut is intense.

Type VI secretion system has been reported to be involved in acquisition of essential micronutrients, such as zinc, manganese, and iron, indicating its novel function in increasing bacterial fitness through competition for essential nutrients. In *Pseudomonas aeruginosa*, the H3-T6SS secreted effector TseF facilitates iron acquisition by interacting with the iron-chelating molecule PQS (Pseudomonas quinolone signal) ([@B55]). In *Burkholderia thailandensis*, T6SS4 secretes zinc- and manganese-scavenging proteins to fulfill the increased cellular demand for these metal ions under oxidative stress ([@B80],[@B81]). Similarly, in the enteric pathogen *Y. pseudotuberculosis*, T6SS4 functions to combat host nutritional immunity and multiple adverse stresses by translocating a zinc binding effector YezP ([@B98]). Distinct from the extensively studied contact-dependent "anti-bacterial" and "anti-eukaryotic" T6SSs, the "metal ion transporting" T6SS secretes metal-binding proteins into the extracellular milieu, independent of cell-cell contact ([@B80]). Thus, T6SS confers survival advantages to bacterium in niches with multiple bacterial species not only by delivering "anti-bacterial" toxins to kill competing cells for interference competition, but also by enhancing its ability to acquire essential micronutrients for exploitation competition. It will be interesting to determine the physiologic consequence of these metal acquisition T6SSs in the intestinal ecosystem in the future.

Interestingly, expression of *Y. pseudotuberculosis* T6SS4 was found to be nutrient status-dependently regulated by the stringent response factor RelA and the nutrient-dependent regulator RovM ([@B84]; [@B105]). Further research is needed to reveal whether T6SS is involved in competition for other nutrients besides metal ions.

Activation of the Innate Immune Response and Virulence {#S2.SS3}
------------------------------------------------------

Although it is well-known that enteric pathogens could utilize the antibacterial T6SS weapon to eradicate competing microbes *in vivo*, little is known about whether the T6SS-dependent interactions with commensal bacteria have additional effects on virulence. Recently, [@B111] discovered that the *V. cholerae* T6SS could compete against commensal *E. coli* strains in the mouse gut to facilitate colonization. Importantly, they found that this microbial antagonistic interaction could improve fitness of *V. cholera* by activating host innate immune responses and improving expression of bacterial virulence genes (i.e., cholera toxin) ([@B111]). The authors suggested that the innate immune response was induced by bacterial debris derived from lysed commensals, which together with up-regulated cholera toxin (CT), resulted in elevated disease symptoms and increased fitness of *V. cholerae* as a pathogen. [@B36] used the *Drosophila melanogaster* model of cholera to define the contribution of T6SS to *V. cholerae* pathogenesis. They found that interactions between T6SS and the gut commensal *Acetobacter pasteurianus* intensified disease symptoms and accelerated host death. The disease severity was attenuated by inactivation of T6SS, or removal of *A. pasteurianus.* Interestingly, mutation of the Immune Deficiency (IMD) pathway relieved T6SS dependent lethality, implicating innate defenses in T6SS-mediated host death ([@B36]). These studies established that interactions between T6SS and commensal bacteria activate innate immune responses and promote *V. cholera* pathogenesis.

In addition, a few T6SS toxic effectors result in metabolic disorders or diseases in eukaryotic host cells. VgrG-1 in *V. cholerae* was responsible for T6SS-dependent cytotoxicity of macrophages through covalent cross-linking of host cell actin ([@B69]; [@B59]). In the diarrheal isolate *Aeromonas hydrophila* SSU, T6SS-secreted VgrG1 exhibited actin ADP-ribosylating activity, which can induce a rounded phenotype in HeLa cells, resulting in apoptosis ([@B87]). A non-VgrG T6SS effector in *Edwardsiella tarda*, EvpP, inhibited NLRP3 inflammasome activation through repression of the Ca^2+^-dependent MAPK-Jnk pathway ([@B21]). T6SS effectors with phospholipase activity could cause damage to the cell membrane and accelerate the infection process ([@B31]; [@B73]). Notably, a few bacterial pathogens with the T6SS apparatus may spread through the digestive tract but cause diseases outside the gastrointestinal system. For example, in the newborn meningitis *E. coli* (NMEC) K1 strain, the Hcps of T6SS interacts with human brain microvascular endothelial cells (HBMEC) in a coordinated manner, first binding, then invading, and finally causing apoptosis of HBMEC ([@B113]). The T6SS-secreted proteins VgrG1 and VgrG2 in *Helicobacter hepaticus* increases cellular innate pro-inflammatory responses, resulting in liver disease and intestinal inflammation ([@B7]).

Modulation of Host Intestinal Mechanics {#S2.SS4}
---------------------------------------

Recently, Logan and colleagues used a combination of microbial genetics, *in vitro* experiments, and quantitative *in vivo* imaging in zebrafish to determine the role of *V. cholerae* T6SS in gut colonization. They found that *V. cholerae* can expel resident microbiota of the genus *Aeromonas* in a T6SS-dependent manner. Unexpectedly, T6SS acted primarily to increase the strength of gut contractions, rather than killing the bacterial competitor. Coupling of T6SS activity to host contractions depended on an actin cross-linking domain (ACD) from the T6SS apparatus. When the ACD domain was deleted, *V. cholerae* could no longer induce enhanced host contractions, and dense *Aeromonas* communities remained in the gut. Deleting the ACD domain did not affect the ability of *V. cholerae* to kill *A. veronii in vitro* or enter and occupy the host intestine. These findings reveal a novel strategy by which enteric pathogens can modulate host intestinal mechanics to redefine gut communities and highlights the role of the host fluid-mechanical environment in shaping gut population dynamics ([@B57]). Whether this is a common tactic for gut-colonizing bacteria to invade the intestinal ecosystem especially in human needs to be verified in the future.

Stress Resistance {#S2.SS5}
-----------------

Within the intestinal lumen, enteric pathogens encounter severe stresses, such as bile salts, antimicrobial peptides, free fatty acids, enhanced osmolarity, and oxidative stress ([@B35]). To survive these adverse environments, bacteria have developed various delicate mechanisms. As a versatile molecular machine, T6SS has been found to play crucial roles in the bacterial stress response and contribute to cell survival under multiple environmental challenges. *Vibrio anguillarum* T6SS is regulated by the general stress response regulator RpoS and is involved in its resistance to hydrogen peroxide, ethanol, and low pH ([@B99]). Upon activation by RpoS and the global oxidative stress regulator OxyR, enterohaemorrhagic *Escherichia coli* (EHEC) uses its T6SS to secrete a Mn-containing catalase, KatN, thus providing a higher resistance to reactive oxygen species (ROS) produced by the host and enhancing survival levels in the host ([@B95]). *Y. pseudotuberculosis* T6SS4 was required for bacterial survival under osmotic, oxidative, and acidic stress and for resistance to bile salts, and its expression was regulated by various stress response regulators, such as the stationary growth phase stress σ factor RpoS, the global oxidative stress regulator OxyR, and the acid/osmotic regulator OmpR ([@B43]; [@B109]; [@B42]; [@B98]). In *V. cholerae* O1, activation of T6SS has been shown to be dependent on the osmolarity of the milieu ([@B48]). In addition, in the intestine, *V. cholerae* T6SS genes are overexpressed under mucin (intestinal host factors) and microbiota-modified bile salt conditions ([@B6]). Bile salts can also activate expression of T6SS genes in *Salmonella typhimurium* ([@B77]) and *C. jejuni* ([@B54]). These studies on gene expression regulation suggest that T6SS is expressed in the intestine and could provide resistance to multiple stresses, increasing bacterial adaptability or survival in the intestinal ecosystem.

Other Potential Functions {#S2.SS6}
-------------------------

Recently, it was suggested that T6SS in *V. cholerae* serves as a predatory weapon and fosters horizontal gene transfer. For incorporation of DNA released by lysed cells into a competent predator cell, natural transformation and evolution can occur ([@B13]). Thus, T6SS may promote co-evolution of bacterial microflora within their environments, including intestinal ecosystems.

Compelling data showed that *H. hepaticus* interacts with intestinal epithelial cells (IECs) and employs T6SS to limit within-host growth and virulence ([@B22]). This feature was regarded as T6SS function of anti-virulence ([@B50]). Nevertheless, this phenomenon is rarely seen.

To summarize, we constructed a schematic diagram showing the functions of T6SS in the intestinal ecosystem ([Figure 1](#F1){ref-type="fig"}).

![Schematic diagram of bacterial T6SS functions in the intestinal ecosystem. T6SS functions verified in the gut (e.g., Competition against other bacteria, Colonization, Virulence, Anti-virulence, Modulation of intestinal mechanics, and Activation of innate immune response.) were marked in red. Deduced T6SS functions in the gut (e.g., Horizontal gene transfer, Metal ions transporting, Stress resistance, and Kill single cell eukaryotic organisms.) based on *in vitro* analysis were shown in the dotted box.](fmicb-10-01484-g001){#F1}

Commensal Intestinal Microbes With T6SS Clusters {#S3}
================================================

Bacteroidetes {#S3.SS1}
-------------

Bacteroidetes, a phylum of Gram-negative bacteria, is highly abundant in the gastrointestinal tracts of humans and other mammals ([@B58]; [@B74]; [@B101]). Despite Bacteroidales being predominant in the mammalian gut, T6SSs in Bacteroidetes species were not identified until 2014, perhaps because the T6SS in Bacteroidetes does not have sufficient sequence similarity with core T6SS proteins of Proteobacteria for protein-protein comparisons (e.g., BLASTP) or protein-profile comparisons (e.g., Pfam, COG) ([@B74]; [@B26]). Studies have revealed that the T6SS loci are segregated into three distinct genetic architectures (GA1-GA3), among which the T6SS loci GA1 and GA2 are contained on highly similar integrative conjugative element (ICE) ([@B26]). Among the numerous mechanisms that compete in the extremely dense ecosystem of the gut, T6SSs are probably very prevalent antagonistic systems in gut Bacteroidales ([@B104]; [@B20]; [@B26]; [@B25]), as the Bacteroides T6SS genes are widespread in human gut metagenomes ([@B93]). Given that T6SSs in Bacteroidetes mediate inter-bacterial antagonism against pathogens and in view of the observed stability of Bacteroidetes in the healthy human intestine, it predicts that T6SS in the stable Bacteroidetes community contributes to intestinal homeostasis. We believe that further research on T6SSs in Bacteroidales species will add to our understanding of microbial stability in the gut and to our ability to diagnose and treat gut microbial infections.

Enteric Pathogens With T6SS Clusters {#S4}
====================================

Vibrio cholerae {#S4.SS1}
---------------

*Vibrio cholerae* is a Gram-negative pathogen consisting of over 200 serogroups that usually cause diarrhoeal diseases ranging from cholera to mild gastroenteritis after ingestion of contaminated food or water containing them ([@B53]; [@B92]). All *V. cholerae* strains examined to date contain T6SS gene clusters ([@B91]). This microorganism provided several important and initial discoveries about T6SS, including the definition of the contact-dependent secretion model ([@B70]; [@B8]), identification of T6SS-dependent effector-immunity pairs ([@B31]; [@B73]; [@B2]), and induction of intestinal inflammation through actin cross-linking in host cells ([@B59]). Recently, *in vivo* analysis presented new insight on the pathogenic mechanism of *V. cholerae* with T6SS. T6SS in *V. cholerae* acts on commensal bacteria *A. pasteurianus* to accelerate death of the *Drosophila* host ([@B36]). Another study revealed the roles of *V. cholerae* T6SS in antagonism against host commensal microbiota *in vivo* over their niche, which facilitated bacterial colonization of the mice gut ([@B111]). Besides killing host gut bacterial symbionts, *V. cholerae* T6SS could modulate host intestinal mechanics, enhancing intestinal movements that led to expulsion of resident microbiota by the host ([@B57]).

Vibrio parahaemolyticus {#S4.SS2}
-----------------------

Research indicated that vpT6SS2 contributed to adhesion of *V. parahaemolyticus* to host cells ([@B107]). In addition, the vpT6SS2 effector could induce autophagy in macrophage cells without causing apparent cytotoxicity ([@B106]).

Salmonella enterica {#S4.SS3}
-------------------

Experiments suggested that T6SS contributed to pathogenicity, at least in the *S. enterica* serotypes Gallinarum ([@B11]), Enteritidis ([@B12]; [@B89]), Typhi ([@B96]), Dublin ([@B67]), and Typhimurium ([@B65]). A recent study provided *in vivo* evidence that *S. typhimurium* used T6SS as a weapon to kill commensal bacteria (*K. oxytoca*) to successfully colonize the mouse gut ([@B77]).

Yersinia pseudotuberculosis {#S4.SS4}
---------------------------

Studies of *Y. pseudotuberculosis* revealed roles for T6SS in responses to various stressors and identified corresponding regulators, including OmpR ([@B43]; [@B109]), OxyR ([@B98]), ZntR ([@B97]), RpoS ([@B42]), RovM ([@B84]), and YpsI/YtbI ([@B110]). Notably, T6SS4 in *Y. pseudotuberculosis* was found to be involved in zinc transportation by secreting a zinc-binding protein YezP to mitigate the impact of detrimental hydroxyl radicals under oxidative stress ([@B98]). The contribution of T6SS to ion transport was also confirmed in *B. thailandensis* and *P. aeruginosa* ([@B55]; [@B80],[@B81]).

Escherichia coli {#S4.SS5}
----------------

*Escherichia coli* are model bacteria that have been studied extensively. Although less abundant than Bacteroidales in the gastrointestinal tract, symbiotic gut *E. coli* play important roles in colonization resistance against enteric pathogens of the proteobacterial phylum ([@B25]). To date, more than 150 *E. coli* strains have been identified. Most are harmless, but several serotypes have been proposed to be pathogenic and may cause significant diarrheal and extraintestinal diseases ([@B28]). The current knowledge regarding the prevalence, the assembly, the regulation, and the roles of the T6SS in *E. coli* has been reviewed ([@B52]). It has been suggested that T6SS contributes to pathogenesis in *E. coli* strains. For example, T6SS-dependent Hcp1 in *E. coli* K1 induced actin cytoskeleton rearrangement, apoptosis, and release of interleukin-6 (IL-6) and IL-8 in human brain microvascular endothelial cells (HBMEC) ([@B113]). Further, T6SS in avian pathogenic *E. coli* (APEC) strains contributes to APEC pathogenesis ([@B62]). Several structural proteins of T6SS in *E. coli* have been studied to clarify the specific functions of these T6SS components ([@B37]; [@B4]; [@B33]). However, whether *E. coli* gut symbionts have T6SSs that function in colonization resistance against enteric pathogens, and how enteric pathogenic *E. coli* T6SSs function in the intestinal ecosystem still remain enigmatic.

Notably, the T6SS apparatus has a common evolutionary origin with phage tail-associated protein complexes. Yet, the involvement of phages in the evolution of bacterial T6SS remains unclear.

Other Enteric Pathogens {#S5}
=======================

Type VI secretion system in some other enteric pathogens has also been studied. In *C. jejuni*, T6SS mediates host cell adhesion, invasion, colonization, and adaptation to deoxycholic acid (DCA) ([@B54]). In *Citrobacter freundii*, T6SS plays a wide-ranging role in the regulation of the flagellar system and in motility; it is also involved in the adherence and cytotoxicity to host cells ([@B56]). T6SS2 in *Vibrio fluvialis* is associated with anti-bacterial activity and contributes to bacteria survival in highly competitive environments ([@B66]). The T6SS effector VgrG1 from *A. hydrophila* induces host cell toxicity by ADP ribosylation of actin ([@B87]). In *E. tarda*, the T6SS effector EvpP significantly inhibits NLRP3 inflammasome activation by inhibiting the Ca^2+^-dependent MAPK-Jnk pathway ([@B21]). Additionally, functional T6SSs have been verified in the enteric pathogens *Enterobacter cloacae* ([@B102]), *Edwardsiella ictaluri* ([@B71]), *Yersinia enterocolitica* ([@B49]), and *V. anguillarum* ([@B99]). To facilitate retrieval for future research, we have listed the experimentally verified intestinal bacteria that contain functional T6SS loci in [Table 1](#T1){ref-type="table"}.

###### 

Intestinal bacteria with functional T6SSs that have been verified experimentally.

  **Bacteria species**            **No. of T6SS loci**   **Experimental strains**                      **T6SS associated phenotypes**                                                  **References**
  ------------------------------- ---------------------- --------------------------------------------- ------------------------------------------------------------------------------- ----------------
  *Aeromonas hydrophila*          1                      SSU                                           Induce host cell toxicity by ADP ribosylation of actin                          [@B87]
  *Bacteroides fragilis*          1                      TM4000, ATCC43858, ATCC43859                  Virulence and strain competition                                                [@B18]
                                                         NCTC 9343, 638R                               Competition                                                                     [@B20]
                                                         NCTC 9343                                     Interbacterial antagonism                                                       [@B74]
  *Campylobacter jejuni*          1                      subsp. *jejuni* serotype O:3                  Host cell adhesion, invasion, colonization; adaptation to DCA                   [@B54]
                                                         108                                           Cytotoxicity toward red blood cells                                             [@B10]
  *Citrobacter freundii*          1--2                   CF74                                          Adhesion and cytotoxicity to host cells                                         [@B56]
  *Citrobacter rodentium*         1--2                   DBS100\[ATCC51459\]                           Interbacterial killing                                                          [@B44]
  *Edwardsiella tarda*            1--2                   EIB202                                        NLRP3 inflammasome inhibition, bacterial colonization *in vivo*                 [@B21]
  *Enterobacter cloacae*          1--2                   subsp. *cloacae* ATCC13047                    Interbacterial competition                                                      [@B108]
  *Escherichia coli*              1--3                   K12 W3110, EAEC 17-2                          Bacterial growth competition                                                    [@B15]
                                                         APEC SEPT362                                  Pathogenesis                                                                    [@B30]
                                                         APEC SEPT362                                  Enhance biofilm formation                                                       [@B29]
                                                         RS218                                         Pathogenicity in HBMEC                                                          [@B113]
                                                         TW-XM (O2:K1)                                 Pathogenic pathways                                                             [@B60]
                                                         EHEC EDL933                                   Virulence                                                                       [@B95]
                                                         STEC                                          Virulence                                                                       [@B1]
  *Helicobacter hepaticus*        1                      ATCC51449                                     Modulate and exacerbate the innate pro-inflammatory effect                      [@B7]
                                                         ATCC51449                                     Limiting colonization and intestinal inflammation                               [@B22]
  *Salmonella enterica*           1--2                   Typhimurium LT2                               Pathogenesis                                                                    [@B65]
                                                         Gallinarum NCTC13346, Enteritidis NCTC13349   Chicken colonization                                                            [@B12]
                                                         Typhi GIFU10007                               Cytotoxicity of human epithelial cells                                          [@B96]
                                                         Typhimurium 14028s                            Chicken colonization                                                            [@B11]
                                                         Dublin CT_02021853                            Colonization of mice and chickens                                               [@B67]
                                                         Enteritidis                                   Virulence                                                                       [@B89]
                                                         SL1344                                        Killing of commensal bacteria, Colonization of the host gut                     [@B77]
  *Shigella sonnei*               1                      CIP106347                                     Interbacterial competition, niche occupancy                                     [@B3]
  *Vibrio alginolyticus*          1--2                   EPGS, MVP01, ATCC33787                        Regulated by QS and RpoN                                                        [@B79]
  *Vibrio anguillarum*            1                      NB10 serotype O1                              Modulates quorum sensing and stress response                                    [@B99]
  *Vibrio cholerae*               1                      C6706                                         Microbial antagonistic interaction, intestinal colonization, virulence          [@B111]
                                                         O37 strain V52                                Virulence, competition                                                          [@B112]
                                                         O37 strain V52                                Intra- and interspecific competition                                            [@B91]
                                                         A1552                                         Foster horizontal gene transfer                                                 [@B13]
                                                         O37 strain V52                                Microbial pathogenesis                                                          [@B70]
                                                         O37 strain V52                                Induces an inflammatory diarrhea                                                [@B59]
                                                         O37 strain V52                                Virulence                                                                       [@B64]
                                                         Multiple strains                              Intraspecific competition                                                       [@B92]
                                                         O37 strain V52                                Interspecies competition                                                        [@B63]
                                                         C6706                                         Intermicrobial competition                                                      [@B57]
  *Vibrio fluvialis*              2                      85003                                         Environmental survival                                                          [@B66]
  *Vibrio parahaemolyticus*       1--2                   HZ                                            Cell adhesion and cytotoxicity                                                  [@B107]
                                                         RIMD 2210633                                  Enhance environmental fitness in marine environments, anti-bacterial activity   [@B75]
                                                         HZ                                            Induce autophagy in macrophages                                                 [@B106]
  *Yersinia enterocolitica*       1                      subsp. *enterocolitica* 8081                  Encumber bacteria invasion and survival in host cells                           [@B49]
  *Yersinia pseudotuberculosis*   4--6                   YpIII                                         Maintain intracellular pH homeostasis                                           [@B109]
                                                         IP31758                                       Survival in high osmolarity, resistance to deoxycholate                         [@B43]
                                                         YpIII                                         Transports Zn^2+^ to combat multiple stresses and host immunity                 [@B98]

Concluding Remarks {#S6}
==================

Although the composition and function of the intestinal microbiota has been well documented, the underlying mechanisms of its assembly remain poorly understood. T6SS is a contact-dependent molecular weapon primarily used for interbacterial competition. Considering that T6SS loci exist in 50% of intestinal Bacteroidetes, which are the dominant microflora in the gastrointestinal system, and in some other commensal intestinal microbes and enteric pathogens, T6SS might be widely used in the intestinal ecosystem to shape microbiota composition. Actually, several seminal studies have greatly advanced our understanding of the importance of T6SS in the intestine. These studies showed that the T6SS antibacterial weapons are not only used by pathogens to colonize their hosts, but also by gut commensals to prevent pathogen colonization. Interestingly, two studies in *V. cholera* further indicated that microbial antagonistic interactions mediated by T6SS could elevate disease symptoms by activating host innate immune responses ([@B36]; [@B111]). Moreover, using a zebrafish model, [@B57] revealed that the T6SS of *V. cholera* could modulate host intestinal mechanics to redefine the gut microbial composition. These findings provide new insights into the mechanisms used by enteric pathogens for gut colonization. As for the gut commensals, [@B93] investigate the prevalence and roles of the T6SS in the human gut microbiome by using metagenomic analyses. In addition to the compatibility with species GA1 and GA2, GA3 is associated with increased Bacteroides abundance in infant microbiomes, and confers an advantage in Bacteroides-rich ecosystems. Thus, it revealed the prevalence and potential role of T6SS-dependent competition in shaping human gut microbial composition ([@B93]).

It is noteworthy that sometimes a few invertebrate models and small animal models (e.g., Drosophila, zebrafish) were used to analyze T6SS functions in the intestinal ecosystem ([@B36]; [@B57]). These results should be further verified in mammalian models. In addition, further *in vivo* studies are urgently needed to confirm whether anti-fungal, stress-resistant and metal ion-acquiring T6SSs are functional in the intestinal ecosystem. Studies of T6SS in the intestinal ecosystem are just beginning and have a long way to go. As T6SS in several bacterial pathogens contributes to virulence against the host, the T6SS apparatus could be exploited as a therapeutic drug target. Based on this possibility, a novel natural antimicrobial was identified that can reduce the pathogenicity of *Campylobacter* T6SS *in vitro* and also decrease its colonization *in vivo* ([@B83]). These findings suggest that studies on T6SS functions in the intestinal ecosystem may provide a theoretical basis for the development of new medicines for various pathogenic infections in the future.
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